Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial
Product details
Registration number: SIN14660P
Classification: Prescription Only
Active ingredients: Meropenem Trihydrate 570 mg eqv to Meropenem anhydrous
Strength: 500mg
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: ALLIANCE PHARM PTE. LTD.
ATC code: J01DH02
HSA approval date: 10 November 2014
Manufacturer(s):
- ACS Dobfar S.p.A
- ACS Dobfar S.p.A. (intermediate)
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14660P
Classification: Prescription Only
What active ingredients and strength are recorded for Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Meropenem Trihydrate 570 mg eqv to Meropenem anhydrous
Strength: 500mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: ALLIANCE PHARM PTE. LTD.
Which manufacturers and countries are listed for Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- ACS Dobfar S.p.A
- ACS Dobfar S.p.A. (intermediate)
Manufacturing country/countries: ITALY
Where can I look up Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14660P or the exact product name Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial. The general register link does not preselect this product.
What are the source dates for this Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14660P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)